Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children

Annals of the American Thoracic Society

Volumn 11, Issue 10, 2014, Pages 1576-1585

  Srinivasan, Ashok ^a,b   Srinivasan, Saumini ^b   Sunthankar, Sudeep ^c   Sunkara, Anusha ^a   Kang, Guolian ^a   Stokes, Dennis C ^b   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Pediatric; Post transplant complications; Pulmonary function

Indexed keywords

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; DEATH; DIFFUSE ALVEOLAR HEMORRHAGE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IDIOPATHIC PNEUMONIA SYNDROME; INFANT; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG FUNCTION TEST; LUNG HEMORRHAGE; LUNG INFECTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OVERALL SURVIVAL; PNEUMONIA; RESIDUAL VOLUME; RETROSPECTIVE STUDY; RISK; T CELL DEPLETION; TOTAL LUNG CAPACITY; VIRUS INFECTION; VITAL CAPACITY; ADVERSE EFFECTS; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LUNG DISEASES; MORBIDITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TENNESSEE; TRENDS; YOUNG ADULT;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES; MALE; MORBIDITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TENNESSEE; VITAL CAPACITY; YOUNG ADULT;

EID: 84920504064     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201407-308OC     Document Type: Article

References (49)

1. Eikenberry M, Bartakova H, Defor T, Haddad IY, Ramsay NKC, Blazar BR, Milla CE, Cornfield DN. Natural history of pulmonary complications in children after bone marrow transplantation. Biol Blood Marrow Transplant 2005;11:56-64.
2. Efrati O, Toren A, Duskin H, Modan-Moses D, Bielorai B, Goldstein G, Churi C, Vilozni D. Pulmonary function studies in children treated by chemoradiotherapy and stem cell transplantation. Pediatr Blood Cancer 2008;51:684-688.
3. Kaya Z, Weiner DJ, Yilmaz D, Rowan J, Goyal RK. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Biol Blood Marrow Transplant 2009;15:817-826.
4. Ginsberg JP, Aplenc R, McDonough J, Bethel J, Doyle J, Weiner DJ. Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation. Pediatr Blood Cancer 2010; 54:454-460.
5. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15: 75-88.
6. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
7. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95 yr age range: The Global Lung Function 2012 equations. Eur Respir J 2012;40:1324-1343.
8. Leung WH, Turner V, Richardson SL, Benaim E, Hale G, Horwitz EM, Woodard P, Bowman LC. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors. Hum Immunol 2001;62:399-407.
9. Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011;118:223-230.
10. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-828.
11. Michelson PH, Goyal R, Kurland G. Pulmonary complications of haematopoietic cell transplantation in children. Paediatr Respir Rev 2007;8:46-61.
12. Gower WA, Collaco JM, Mogayzel PJ Jr. Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: non-infectious and long-term complications. Pediatr Blood Cancer 2007;49: 225-233.
13. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26:153-161.
14. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity [ATS Workshop on Lung Volume Measurements; official statement of the European Respiratory Society]. Eur Respir J 1995;8:492-506.
15. Kim YJ, Hall GL, Christoph K, Tabbey R, Yu Z, Tepper RS, Eigen H. Pulmonary diffusing capacity in healthy Caucasian children. Pediatr Pulmonol 2012;47:469-475.
16. Paoletti P, Viegi G, Pistelli G, Di Pede F, Fazzi P, Polato R, Saetta M, Zambon R, Carli G, Giuntini C, et al. Reference equations for the single-breath diffusing capacity: A cross-sectional analysis and effect of body size and age. Am Rev Respir Dis 1985;132:806-813.
17. Quanjer PH, Pretto JJ, Brazzale DJ, Boros PW. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J 2014;43: 505-512.
18. Parimon T, Madtes DK, Au DH, Clark JG, Chien JW. Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med 2005;172:384-390.
19. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978;34:541-554.
20. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-1154.
21. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. JASA 1999;94:496-509.
22. Johnson FL, Stokes DC, Ruggiero M, Dalla-Pozza L, Callihan TR. Chronic obstructive airways disease after bone marrow transplantation. J Pediatr 1984;105:370-376.
23. Horak DA, Schmidt GM, Zaia JA, Niland JC, Ahn C, Forman SJ. Pretransplant pulmonary function predicts cytomegalovirusassociated interstitial pneumonia following bone marrow transplantation. Chest 1992;102:1484-1490.
24. Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow MR, Aubry MC, Afessa B. Pulmonary complications in adult blood and marrow transplant recipients: Autopsy findings. Chest 2005;128: 1385-1392.
25. Erard V, Chien JW, Kim HW, Nichols WG, Flowers ME, Martin PJ, Corey L, Boeckh M. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: The role of community respiratory viruses. J Infect Dis 2006;193:1619-1625.
26. Inaba H, Yang J, Pan J, Stokes DC, Krasin MJ, Srinivasan A, Hartford CM, Pui CH, Leung W. Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation. Cancer 2010;116: 2020-2030.
27. Quanjer PH, Weiner DJ. Interpretative consequences of adopting the Global Lungs 2012 reference equations for spirometry for children and adolescents. Pediatr Pulmonol 2014;49:118-125.
28. Motosue MS, Zhu L, Srivastava K, Stokes DC, Hudson MM, McPherson V, Srinivasan S, Krasin MJ, Green DM, Spunt SL, et al. Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. Cancer 2012;118:1450-1456.
29. Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: A systematic review. Chest 2011;140:881-901.
30. Freudenberger TD, Madtes DK, Curtis JR, Cummings P, Storer BE, Hackman RC. Association between acute and chronic graft-versushost disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003;102: 3822-3828.
31. Schwarer AP, Hughes JM, Trotman-Dickenson B, Krausz T, Goldman JM. A chronic pulmonary syndrome associated with graft-versushost disease after allogeneic marrow transplantation. Transplantation 1992;54:1002-1008.
32. Patriarca F, Skert C, Sperotto A, Damiani D, Cerno M, Geromin A, Zaja F, Stocchi R, Prosdocimo S, Fili' C, et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004;33:751-758.
33. Chakrabarti S, Collingham KE, Marshall T, Holder K, Gentle T, Hale G, Fegan CD, Milligan DW. Respiratory virus infections in adult T cell- depleted transplant recipients: The role of cellular immunity. Transplantation 2001;72:1460-1463.
34. Srinivasan A, Wang C, Srivastava DK, Burnette K, Shenep JL, Leung W, Hayden RT. Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013;19:94-101.
35. Hoffmeister PA, Madtes DK, Storer BE, Sanders JE. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer 2006;47:594-606.
36. Leung W, Ahn H, Rose SR, Phipps S, Smith T, Gan K, O'Connor M, Hale GA, Kasow KA, Barfield RC, et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007;86:215-224.
37. Ghalie R, Szidon JP, Thompson L, Nawas YN, Dolce A, Kaizer H. Evaluation of pulmonary complications after bone marrow transplantation: The role of pretransplant pulmonary function tests. Bone Marrow Transplant 1992;10:359-365.
38. Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF. Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 1998;16:3796-3802.
39. Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 1992;101:1257-1264.
40. Ramirez-Sarmiento A, Orozco-Levi M, Walter EC, Au MA, Chien JW. Influence of pretransplantation restrictive lung disease on allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant 2010;16:199-206.
41. Piñana JL, Martino R, Barba P, Bellido-Casado J, Valcárcel D, Sureda A, Briones J, Brunet S, Rodriguez-Arias JM, Casan P, et al. Pulmonary function testing prior to reduced intensity conditioning allogeneic stem cell transplantation in an unselected patient cohort predicts posttransplantation pulmonary complications and outcome. Am J Hematol 2012;87:9-14.
42. Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993;12:225-231.
43. Baron F, Labopin M, Niederwieser D, Vigouroux S, Cornelissen JJ, Malm C, Vindelov LL, Blaise D, Janssen JJ, Petersen E, et al. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Leukemia 2012;26: 2462-2468.
44. Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transplant 2012;18: 1727-1733.
45. Chien JW, Maris MB, Sandmaier BM, Maloney DG, Storb RF, Clark JG. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11: 288-296.
46. Singh AK, Karimpour SE, Savani BN, Guion P, Hope AJ, Mansueti JR, Ning H, Altemus RM, Wu CO, Barrett AJ. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant. Int J Radiat Oncol Biol Phys 2006;66:520-527.
47. 75% does not contribute to clinical decision making. Eur Respir J 2014;43:1051-1058.
48. Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med 2000;161:1924-1929.
49. Sritippayawan S, Keens TG, Horn MV, Starnes VA, Woo MS. What are the best pulmonary function test parameters for early detection of post-lung transplant bronchiolitis obliterans syndrome in children? Pediatr Transplant 2003;7:200-203.